Regulatory T cells (Treg) in rheumatoid arthritis

被引：95

作者：

Boissier, Marie-Christophe ^{[1
,2
,3
]}

Assier, Eric ^{[1
,2
,3
]}

Biton, Jerome ^{[1
,2
,3
]}

Denys, Anne ^{[1
,2
,3
]}

Falgarone, Geraldine ^{[1
,2
,3
]}

Bessis, Natacha ^{[1
,2
,3
]}

机构：

[1] CHU Avicenne, Serv Rhumatol, AP HP, F-93009 Bobigny, France

[2] INSERM, ER118, Bobigny, France

[3] Univ Paris 13, EA4222, F-93430 Villetaneuse, France

来源：

JOINT BONE SPINE | 2009年 / 76卷 / 01期

关键词：

T lymphocytes; Rheumatoid arthritis; Immunomodulation; Cytokines; Cell therapy; Regulatory T lymphocytes; COLLAGEN-INDUCED ARTHRITIS; PERIPHERAL-BLOOD; AUTOIMMUNE-DISEASES; SYNOVIAL-FLUID; IN-VIVO; FOXP3; SUPPRESSION; INDUCTION; TOLERANCE; EXPANSION;

D O I：

10.1016/j.jbspin.2008.08.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Modulation of the T-cell response depends chiefly on regulatory T cells (Treg), which express CD4 and CD25. Some Treg cells are present naturally, whereas others are induced in response to antigens. The immunomodulating effects of Treg cells are mediated by membrane molecules (e.g., CTLA4, GITR, and OX40) and cytokines. IL-35 seems to be a crucial mediator, although IL-10 and TGF beta are also important. The role for Treg cells in rheumatoid arthritis (RA) has been established in both patients and animal models. Treg function is deficient in RA, whereas Treg counts vary. Treg counts increase in patients who are responding to TNF alpha antagonist therapy. Among current hypotheses, Treg expansion or transfer may hold promise for the treatment of RA. (C) 2008 Elsevier Masson SAS. All rights reserved.

引用

页码：10 / 14

页数：5

共 32 条

[1] Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis
Balandina, A
Lécart, S
Dartevelle, P
Saoudi, A
Berrih-Aknin, S
[J]. BLOOD, 2005, 105 (02) : 735 - 741
[2] The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
Bennett, CL
Christie, J
Ramsdell, F
Brunkow, ME
Ferguson, PJ
Whitesell, L
Kelly, TE
Saulsbury, FT
Chance, PF
Ochs, HD
[J]. NATURE GENETICS, 2001, 27 (01) : 20 - 21
[3] Role for suppressor T cells in the pathogenesis of autoimmune diseases (including rheumatoid arthritis). Facts and hypotheses
Berthelot, JM
Maugars, Y
[J]. JOINT BONE SPINE, 2004, 71 (05) : 374 - 380
[4] Shifting the imbalance from Th1/Th2 to Th17/treg: The changing rheumatoid arthritis paradigm
Boissier, Marie-Christophe
Assier, Eric
Falgarone, Geraldine
Bessis, Natacha
[J]. JOINT BONE SPINE, 2008, 75 (04) : 373 - 375
[5] CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease
Cao, DJ
van Vollenhoven, R
Klareskog, L
Trollmo, C
Malmström, V
[J]. ARTHRITIS RESEARCH & THERAPY, 2004, 6 (04) : R335 - R346
[6] Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of CD49b+ regulatory T cells
Charbonnier, Louis-Marie
van Duivenvoorde, Leonie M.
Apparailly, Florence
Cantos, Celine
Han, Wanda G. H.
Noel, Daniele
Duperray, Christophe
Huizinga, Tom W. J.
Toes, Rene E. M.
Jorgensen, Christian
Louis-Plence, Pascale
[J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (06) : 3806 - 3813
[7] The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, Lauren W.
Workman, Creg J.
Kuo, Timothy T.
Boyd, Kelli
Wang, Yao
Vignali, Kate M.
Cross, Richard
Sehy, David
Blumberg, Richard S.
Vignali, Dario A. A.
[J]. NATURE, 2007, 450 (7169) : 566 - U19
[8] Quantification of regulatory T cells in patients with systemic lupus erythematosus
Crispin, JC
Martínez, A
Alcocer-Varela, J
[J]. JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) : 273 - 276
[9] CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis
de Kleer, IM
Wedderburn, LR
Taams, LS
Patel, A
Varsani, H
Klein, M
de Jager, W
Pugayung, G
Giannoni, F
Rijkers, G
Albani, S
Kuis, W
Prakken, B
[J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (10) : 6435 - 6443
[10] Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy
Ehrenstein, MR
Evans, JG
Singh, A
Moore, S
Warnes, G
Isenberg, DA
Mauri, C
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) : 277 - 285

← 1 2 3 4 →